Skip to content

The Policy Vault

Methodology Why Contact

Coverage / Highmark / Calquence Acalabrutinib

Calquence Acalabrutinib — Highmark

5 indications indexed for this drug.

Any Covered Indication For A Btk Inhibitor
View coverage criteria
Chronic Lymphocytic Leukemia Cll
View coverage criteria
Mantle Cell Lymphoma Mcl
View coverage criteria
Quantity Limit Exception
View coverage criteria
Small Lymphocytic Lymphoma Sll
View coverage criteria

The Policy Vault

Structured prior authorization and step-therapy criteria for commercial health plans. Built by pharmacists for healthcare professionals.

Disclaimer: Educational use only. Coverage varies by employer group and formulary. Always verify with the plan.

Product

Coverage Directory
Why Policy Vault
Methodology

Company

Contact
Press
Support

© 2025 The Policy Vault. Data sourced from official health plan documents.